Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-24 @ 11:41 PM
NCT ID:
NCT04632251
Eligibility Criteria:
Inclusion Criteria:
* Male subjects who are ≥ 18 years of age with histologically proven prostate cancer; and who have signed an informed consent form prior to any study related activity • Subjects who are scheduled for radical prostatectomy with ePLND.
Exclusion Criteria:
* Subjects who have received prior prostate cancer treatment or prior pelvic surgery;
* Subjects who have an existing medical condition that would compromise their participation in the study;
* Subjects with a history of hypersensitivity to 99mTc-nanocolloid or any excipients;
* Subjects who are unable to give voluntary, written informed consent to participate in this study;
* Subjects who are unable to understand this study and are not willing to complete all the study assessments.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT04632251
Study Brief:
Protocol Section:
NCT04632251